BlackRock’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.79M Sell
653,840
-19,210
-3% -$200K ﹤0.01% 3555
2025
Q1
$8.87M Buy
673,050
+13,648
+2% +$180K ﹤0.01% 3336
2024
Q4
$11.8M Buy
659,402
+235,936
+56% +$4.23M ﹤0.01% 3299
2024
Q3
$6.83M Buy
423,466
+15,870
+4% +$256K ﹤0.01% 3534
2024
Q2
$11M Buy
407,596
+165,797
+69% +$4.48M ﹤0.01% 3288
2024
Q1
$4.72M Sell
241,799
-8,799
-4% -$172K ﹤0.01% 3637
2023
Q4
$5.18M Sell
250,598
-7,575
-3% -$157K ﹤0.01% 3606
2023
Q3
$8.21M Sell
258,173
-4,531
-2% -$144K ﹤0.01% 3397
2023
Q2
$8.83M Buy
262,704
+182,434
+227% +$6.13M ﹤0.01% 3403
2023
Q1
$3.35M Sell
80,270
-1,838
-2% -$76.6K ﹤0.01% 3733
2022
Q4
$2.78M Buy
82,108
+1,495
+2% +$50.7K ﹤0.01% 3915
2022
Q3
$3.97M Buy
80,613
+1,457
+2% +$71.7K ﹤0.01% 3779
2022
Q2
$3.11M Sell
79,156
-146,339
-65% -$5.75M ﹤0.01% 3956
2022
Q1
$8.32M Sell
225,495
-6,234
-3% -$230K ﹤0.01% 3598
2021
Q4
$22.7M Sell
231,729
-458
-0.2% -$44.8K ﹤0.01% 3137
2021
Q3
$29M Buy
232,187
+9,154
+4% +$1.14M ﹤0.01% 2993
2021
Q2
$28M Buy
223,033
+14,963
+7% +$1.88M ﹤0.01% 3044
2021
Q1
$28.2M Buy
208,070
+25,593
+14% +$3.47M ﹤0.01% 2941
2020
Q4
$16.6M Buy
182,477
+35,302
+24% +$3.21M ﹤0.01% 3041
2020
Q3
$11M Buy
147,175
+15,252
+12% +$1.13M ﹤0.01% 3096
2020
Q2
$11.2M Buy
131,923
+108,744
+469% +$9.27M ﹤0.01% 3054
2020
Q1
$1.68M Buy
23,179
+1,211
+6% +$87.5K ﹤0.01% 3641
2019
Q4
$1.57M Sell
21,968
-436
-2% -$31.1K ﹤0.01% 3799
2019
Q3
$1.18M Buy
22,404
+143
+0.6% +$7.51K ﹤0.01% 3872
2019
Q2
$1.2M Sell
22,261
-34,138
-61% -$1.83M ﹤0.01% 3902
2019
Q1
$4.01M Buy
56,399
+26,446
+88% +$1.88M ﹤0.01% 3451
2018
Q4
$2.39M Buy
29,953
+37
+0.1% +$2.95K ﹤0.01% 3583
2018
Q3
$14M Buy
29,916
+431
+1% +$201K ﹤0.01% 3039
2018
Q2
$11.7M Buy
29,485
+8,486
+40% +$3.37M ﹤0.01% 3132
2018
Q1
$6.42M Buy
20,999
+325
+2% +$99.4K ﹤0.01% 3289
2017
Q4
$6.09M Buy
20,674
+1,375
+7% +$405K ﹤0.01% 3327
2017
Q3
$10.6M Buy
19,299
+2,616
+16% +$1.43M ﹤0.01% 3096
2017
Q2
$9.94M Buy
16,683
+9,730
+140% +$5.8M ﹤0.01% 3135
2017
Q1
$2.99M Buy
6,953
+6,947
+115,783% +$2.98M ﹤0.01% 3506
2016
Q4
$3K Buy
+6
New +$3K ﹤0.01% 3534